The DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.
Synergistic antitumor activity of withaferin A combined with oxaliplatin triggers reactive oxygen species-mediated inactivation of the PI3K/AKT pathway in human pancreatic cancer cells
Abstract
Application of oxaliplatin for the treatment of pancreatic cancer (PC) is restricted owing to its toxic side effects and drug resistance. We investigated how withaferin A (WA), a bioactive component isolated from the medicinal plant Withania somnifera, acts synergistically with oxaliplatin on human PC in vitro and in vivo. We found that WA enhanced oxaliplatin-induced growth suppression and apoptosis in PC cells dramatically through a mechanism involving mitochondrial dysfunction and inactivation of the PI3K/AKT pathway. Combination treatment resulted in significant accumulation of intracellular reactive oxygen species (ROS). Pretreatment of cells with the ROS scavenger N-acetylcysteine completely blocked the apoptosis induced by combination treatment, and recovered expression of AKT inactivation, which revealed the important role of ROS in apoptosis and AKT regulation. In vivo, combination therapy showed the strongest anti-tumor effects compared with single agents, without obvious additional toxicity. These results support the notion that combination treatment with oxaliplatin and WA could facilitate development of an effective strategy for PC treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Quercetin-3-rutinoside-7-glucoside, rutin, and isochlorogenic acid B from WS worked better than withanolide and withanone against chief protease of SARS-CoV2 [184].”
From Withania somnifera (L.) Dunal (Ashwagandha): A comprehensive review on ethnopharmacology, pharmacotherapeutics, biomedicinal and toxicological aspects (2021) · cites this paper as [184]
Citations
Cites
1 retracted
Banerjee, S., Wang, Z., Kong, D., & Sarkar, F. H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0838 · Cited by 98
RetractedMitochondrial membrane permeabilization in cell death
Kroemer, G., Galluzzi, L., & Brenner, C. (2007) · Physiological Reviews · doi:10.1152/physrev.00013.2006 · Cited by 3,598
Reactive oxygen species, cellular redox systems, and apoptosis
Circu, M. L., & Aw, T. Y. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.12.022 · Cited by 3,340
Mitochondria and cell death: outer membrane permeabilization and beyond
Tait, S. W. G., & Green, D. R. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2952 · Cited by 2,593
Oettle, H., Post, S., Neuhaus, P., Gellert, K., Langrehr, J. M., Ridwelski, K., Schramm, H., Fahlke, J., Zuelke, C., Burkart, C., et al. (2007) · JAMA · doi:10.1001/jama.297.3.267 · Cited by 2,418
Shimizu, S., Narita, M., Tsujimoto, Y., & Tsujimoto, Y. (1999) · Nature · doi:10.1038/20959 · Cited by 2,178
Redox regulation of cell survival
Trachootham, D., Lu, W., Ogasawara, M. A., Valle, N. R.-D., & Huang, P. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1957 · Cited by 1,781
Targeting Apoptosis Pathways in Cancer Therapy
Ghobrial, I. M., Witzig, T. E., & Adjei, A. A. (2005) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.3.178 · Cited by 1,369
Reactive oxygen species in cancer cells: Live by the sword, die by the sword
Schumacker, P. T. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.015 · Cited by 1,242
Kindler, H. L., Niedzwiecki, D., Hollis, D. R., Sutherland, S., Schrag, D., Hurwitz, H. I., Innocenti, F., Mulcahy, M. F., O'Reilly, E. M., Wozniak, T. F., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.1386 · Cited by 848
Cited by
Sorted by citations
Natural Products as Anticancer Agents: Current Status and Future Perspectives
Naeem, A., Hu, P., Yang, M. Y., Zhang, J., Liu, Y., Zhu, W., & Zheng, Q. (2022) · Molecules · doi:10.3390/molecules27238367 · Cited by 646
Paul, S., Chakraborty, S., Anand, U., Dey, S., Nandy, S., Ghorai, M., Saha, S. C., Patil, M. T., Kandimalla, R., Proćków, J., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112175 · Cited by 306
Targeting Cdc20 as a novel cancer therapeutic strategy
Wang, L., Zhang, J., Wan, L., Zhou, X., Wang, Z. P., & Wei, W. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.04.002 · Cited by 251
Zhang, H., Pan, Y., Cheung, M., Cao, M. P.-J., Yu, C., Chen, L., Zhan, L., He, Z., & Sun, C. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1320-z · Cited by 176
Phytochemicals in cancer cell chemosensitization: Current knowledge and future perspectives
Khatoon, E., Banik, K., Harsha, C., Sailo, B. L., Thakur, K. K., Khwairakpam, A. D., Vikkurthi, R., Devi, T. B., Gupta, S. C., & Kunnumakkara, A. B. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.06.014 · Cited by 163
Yu, W., Wang, Y., Zhu, J., Jin, L., Liu, B., Xia, K., Wang, J., Gao, J., Liang, C., & Tao, H. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.11.019 · Cited by 140
Wen, C., Wang, H. H., Wu, X., He, L., Zhou, Q., Wang, F., Chen, S., Huang, L. J., Chen, J., Wang, H., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2035-x · Cited by 130
Reactive Oxygen Species and Targeted Therapy for Pancreatic Cancer
Zhang, L., Li, J., Zong, L., Chen, X., Chen, K., Jiang, Z., Nan, L., Li, X., Li, W., Shan, T., et al. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1616781 · Cited by 130
“The release of superoxide anion, hydrogen peroxide, and hydroxyl radicals by macrophages and neutrophils is sustained by activation of plasma membrane NADPH oxidase [21].”
BackgroundWithaferin A: From ayurvedic folk medicine to preclinical anti-cancer drug
Hassannia, B., Logie, E., Vandenabeele, P., Berghe, T. V., & Berghe, W. V. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.08.004 · Cited by 129
Emerging mechanisms and applications of ferroptosis in the treatment of resistant cancers
Li, B., Yang, L., Peng, X., Fan, Q., Wei, S., Yang, S., Li, X., Jin, H., Wu, B., Huang, M., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110710 · Cited by 104
Exploring the Multifaceted Therapeutic Potential of Withaferin A and Its Derivatives
Behl, T., Sharma, A., Sharma, L. K., Sehgal, A., Zengin, G., Brata, R. D., Frățilă, O., & BUNGAU, S. G. (2020) · Biomedicines · doi:10.3390/biomedicines8120571 · Cited by 100
“While in vivo methodology evaluated high synergistic antitumor activity in PC xenografts [81].”
BackgroundInfluentialJúnior, R. G. D. O., Adrielly, A. F. C., Almeida, J. R. G. D. S., Grougnet, R., Thiéry, V., & Picot, L. (2018) · Fitoterapia · doi:10.1016/j.fitote.2018.02.025 · Cited by 96
“…weekly (i.p.) Xenograft (Mi/M) Synergistic decrease in tumor volume and weight, synergistic induction of apoptosis (pancreatic cancer) Y N Li et al. (2015) [117] α-carotene 5 mg/kg/day (p.o.) PTX 6 mg/kg/day (i.p.) Xenograft (Mi/M) Synergistic decrease in lung metastasis (lung cancer) Y…”
BackgroundInfluentialZhang, Y., Li, Q., Wang, J., Cheng, F., Huang, X., Cheng, Y., & Wang, K. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.04.037 · Cited by 100
Withaferin A Induces Oxidative Stress-Mediated Apoptosis and DNA Damage in Oral Cancer Cells
Chang, H., Li, R.-N., Wang, H.-R., Liu, J.-R., Tang, J., Huang, H., Chan, Y., & Yen, C.-Y. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00634 · Cited by 91
Natural products as chemo-radiation therapy sensitizers in cancers
Nisar, S., Masoodi, T., Prabhu, K. S., Kuttikrishnan, S., Zarif, L., Khatoon, S., Ali, S. M., Shahab Uddin, M. S., Akil, A. A., Singh, M. K., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113610 · Cited by 90
Kumar, S., Mathew, S. O., Aharwal, R. P., Tuli, H. S., Mohan, C. D., Sethi, G., Ahn, K. S., Webber, K. J., Sandhu, S. S., & Bishayee, A. (2023) · Pharmaceuticals · doi:10.3390/ph16020160 · Cited by 90
Sivasankarapillai, V. S., Nair, R. M. K., Rahdar, A., BUNGAU, S. G., Zaha, D. C., Aleya, L., & Ţiţ, D. M. (2020) · Environmental Science and Pollution Research · doi:10.1007/s11356-020-09028-0 · Cited by 77
“Western blotting studies the presence of client proteins by inhibiting the HSP90.”
BackgroundInfluentialWithaferin A inhibits Epithelial to Mesenchymal Transition in Non-Small Cell Lung Cancer Cells
Kyakulaga, A. H., Aqil, F., Munagala, R., & Gupta, R. C. (2018) · Scientific Reports · doi:10.1038/s41598-018-34018-1 · Cited by 74
Wang, X., Zhang, H., Yin, S., Yang, Y., Yang, H., Yang, J., Zhou, Z., Li, S., Ying, G., & Ba, Y. (2021) · EMBO Reports · doi:10.15252/embr.202153140 · Cited by 72
Mohan, A., Narayanan, S., Gopalan, B., Sethuraman, S., & Krishnan, U. M. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.11.017 · Cited by 64
Tewari, D., Chander, V., Dhyani, A., Sahu, S. K., Gupta, P. K., Patni, P., Kalick, L. S., & Bishayee, A. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.153949 · Cited by 66
Phytochemicals, withaferin A and carnosol, overcome pancreatic cancer stem cells as c-Met inhibitors
Aliebrahimi, S., Montasser-Kouhsari, S., Arab, S. S., Shadboorestan, A., & Ostad, S. N. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.055 · Cited by 62
Kashyap, V. K., Peasah-Darkwah, G., Dhasmana, A., Jaggi, M., Yallapu, M. M., & Chauhan, S. C. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030611 · Cited by 68
Bretin, L., Pinon, A., Bouramtane, S., Ouk, C., Richard, L., Perrin, M.-L., Chaunavel, A., Carrion, C., Bregier, F., Sol, V., et al. (2019) · Cancers · doi:10.3390/cancers11101474 · Cited by 62
“PDT-induced ROS-generation triggers mitochondrial pore-opening leading to caspase activation and thus induces apoptotic cell death [50,51].”
BackgroundInhibition of Autophagy by Deguelin Sensitizes Pancreatic Cancer Cells to Doxorubicin
Xu, X., Zhao, Y., Zhang, M., He, R., Shi, X., Guo, X., Shi, C.-J., Peng, F., Wang, M., Shen, M., et al. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020370 · Cited by 60
“Previous studies indicate that inhibition of autophagy enhances the efficacy of anticancer drugs, suggesting that suppression of autophagy may be an effective anti-cancer therapeutic strategy [21-23].”
BackgroundXing, Z., Su, A., Li, M., Zhang, Y., He, T., Qiu, Y., Wei, T., Li, Z., Zhu, J., & Wu, W. (2023) · Drug Design Development and Therapy · doi:10.2147/dddt.s422512 · Cited by 55
Withania somnifera (L.) Dunal: A potential therapeutic adjuvant in cancer
Saggam, A., Tillu, G. S., Dixit, S., Chavan, P., Borse, S., Joshi, K., & Patwardhan, B. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.112759 · Cited by 55
Hegab, A. M. M., Hassanin, S. O., Mekky, R. H., Abuzahrah, S. S., Hamza, A. A., Talaat, I. M., & Amin, A. (2025) · Pharmaceuticals · doi:10.3390/ph18020248 · Cited by 54
“According to Li et al. [84] withaferin A suppresses the PI3K/AKT pathway, which causes mitochondrial dysfunction.”
Yu, W., Zhu, J., Wang, Y., Wang, J., Fang, W., Xia, K., Shao, J., Wu, M.-Z., Liu, B., Liang, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16243 · Cited by 51
“ROS decreases the PI3K/AKT signaling pathway, induced by mitochondrial damage, leading to mitochondrion-mediated apoptosis [63].”
BackgroundYue, T., Zuo, S., Bu, D., Zhu, J., Chen, S., Ma, Y., Ma, J., Guo, S., Wen, L., Zhang, X., et al. (2020) · Journal of Cancer · doi:10.7150/jca.35375 · Cited by 50
“Previous studies have shown that Bcl-2 family proteins also regulate mitochondrial apoptosis pathways [31, 32].”
BackgroundBhat, J. A., Akther, T., Najar, R. A., Rasool, F., & Hamid, A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1029123 · Cited by 51
“This offered the strongest proof to yet of the combination therapy of withaferin A and oxaliplatin’s anticancer efficacy in PanCa therapy (Li et al., 2015).”
BackgroundWithania somnifera Suppresses Tumor Growth of Intracranial Allograft of Glioma Cells
Kataria, H., Sushil Kumar, K., Chaudhary, H., & Kaur, G. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9320-1 · Cited by 47
Zhang, S., Shi, L., Ma, H., Li, H., Li, Y., Lu, Y., Wang, Q., & Li, W. (2016) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2016.1203942 · Cited by 46
Withania somnifera Induces Cytotoxic and Cytostatic Effects on Human T Leukemia Cells
Turrini, E., Calcabrini, C., Sestili, P., Catanzaro, E., Gianni, E. D., Diaz, A., Hrelia, P., Tacchini, M., Guerrini, A., Canonico, B., et al. (2016) · Toxins · doi:10.3390/toxins8050147 · Cited by 46
“Many studies have demonstrated the role of WFA inducing oxidative stress as an anticancer strategy on different tumor cell lines, such as prostate cancer, breast cancer, pancreatic cancer, leukemia, and melanoma [30–34].”
Oral administration of withaferin A inhibits carcinogenesis of prostate in TRAMP model
Suman, S., Das, T. P., Moselhy, J., Pal, D., Kolluru, V., Alatassi, H., Ankem, M. K., & Damodaran, C. (2016) · Oncotarget · doi:10.18632/oncotarget.10733 · Cited by 45
Ma, T., Zhang, Y., Zhang, C., Luo, J., & Kong, L. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.07.018 · Cited by 44
Abdel-Wahhab, K. G., Mourad, H. H., Mannaa, F. A. E., Morsy, F. A., Hassan, L. K., & Taher, R. F. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-04721-x · Cited by 47
Zúñiga, R., Concha, G., Cayo, Á., Cikutović-Molina, R., Arévalo, B., González, W., Catalán, M. A., & Zúñiga, L. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110383 · Cited by 40
Sang, J., Gan, L., Zou, M.-F., Lin, Z., Fan, R., Huang, J.-L., Li, W., Tang, G., & Yin, S. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.11.014 · Cited by 40
Yu, P., Zhang, C., Gao, C., Ma, T., Zhang, H., Zhou, M., Yang, Y.-W., Yang, L., & Kong, L. (2017) · Oncotarget · doi:10.18632/oncotarget.19299 · Cited by 38
“Furthermore, emerging evidences illustrated that natural compounds such as Physalin A [51], withaferin A [27] and celastrol [11] can cause ROS-mediated apoptosis and autophagy due to their structure of α, β-unsaturated ketone moieties [52].”
BackgroundYu, T., Tang, J., Ou‐Yang, F., Wang, Y., Yuan, S. F., Tseng, K., Lin, L., & Chang, H. (2020) · Biomolecules · doi:10.3390/biom10050777 · Cited by 38
“Withaferin A (WFA), a triterpenoid derived from the root or leaf of the medicinal plant Withania somnifera, is reported to exhibit antiproliferative properties and can induce apoptosis in several types of cancers such as leukemia [5], cervical [6], pancreatic [7], breast [8], lung [9], colorectal [10], and oral [11,12…”
BackgroundDai, G., Zheng, D., Wang, Q., Yang, J., Liu, G., Song, Q., Sun, X., Tao, C., Hu, Q., Gao, T., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20987 · Cited by 36
“In general, there are two major apoptotic pathways: the extrinsic (death receptor-mediated) pathway and the intrinsic (mitochondrial-mediated) pathway, both pathways contribute to the drug induced apoptosis of tumor cells [44, 45].”
BackgroundPractical Application of “About Herbs” Website
Hou, Y.-N., Deng, G. E., & Mao, J. J. J. (2019) · The Cancer Journal · doi:10.1097/ppo.0000000000000403 · Cited by 35
Kyakulaga, A. H., Aqil, F., Munagala, R., & Gupta, R. C. (2020) · Oncotarget · doi:10.18632/oncotarget.27519 · Cited by 36
“Several studies have used CI and DRI to investigate the synergistic effects of anticancer drugs against breast [32], lung, pancreatic [40] and ovarian [39] cancers.”
Kalli, M., Mpekris, F., Charalambous, A., Michael, C., Stylianou, C., Voutouri, C., Hadjigeorgiou, A. G., Papoui, A., Martin, J. D., & Stylianopoulos, T. (2024) · Communications Biology · doi:10.1038/s42003-024-07268-1 · Cited by 35
Withanolides: Promising candidates for cancer therapy
Zhang, Q., Yuan, Y., Cao, S., Kang, N., & Qiu, F. (2024) · Phytotherapy Research · doi:10.1002/ptr.8090 · Cited by 35
Scalcon, V., Folda, A., Lupo, M. G., Tonolo, F., Pei, N., Battisti, I., Ferri, N., Arrigoni, G., Bindoli, A., Holmgren, A., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102277 · Cited by 35
Potential Anticancer Properties and Mechanisms of Action of Withanolides
Samadi, A. K. (2015) · The Enzymes · doi:10.1016/bs.enz.2015.05.002 · Cited by 32
Qian, Y., Xu, S., Yang, X., & Xiao, Q. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24119 · Cited by 29
“MDA is a terminal product of lipid peroxidation (Li et al., 2015).”
BackgroundMechanisms of Anti-Tumor Activity of Withania somnifera (Ashwagandha)
Mehta, V., Chander, H., & Munshi, A. (2020) · Nutrition and Cancer · doi:10.1080/01635581.2020.1778746 · Cited by 29
“with apoptosis induction and inactivation of Akt phosphorylation (82).”
BackgroundWithaferin a Triggers Apoptosis and DNA Damage in Bladder Cancer J82 Cells through Oxidative Stress
Chien, T., Wu, K., Chuang, Y.-T., Yeh, Y., Wang, H., Yeh, B., Yen, C., Yu, T., Wu, W., & Chang, H. (2021) · Antioxidants · doi:10.3390/antiox10071063 · Cited by 25
“5 μM (48 h sulforhodamine B assay), and 1–2 μM (48 h Alamar Blue assay) for oral [12], cervical [13], glioblastoma [14], pancreatic [15], lung [16], and melanoma [17] types.”
T-2 mycotoxin Induces male germ cell apoptosis by ROS-mediated JNK/p38 MAPK pathway
Lee, W.-Y., & Park, H.-J. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.115323 · Cited by 25
Withania somnifera Root Extract Enhances Chemotherapy through ‘Priming’
Henley, A. B., Yang, L., Chuang, K.-L., Sahuri-Arisoylu, M., Wu, L.-H., Bligh, S. W. A., & Bell, J. D. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170917 · Cited by 23
Peng, S., Wang, Y., Lan, T., Lin, L., Yuan, S. F., Tang, J., & Chang, H. (2020) · Antioxidants · doi:10.3390/antiox9111120 · Cited by 22
“For example, the combined treatment of WFA and oxaliplatin showed synergistic antitumor activity in pancreatic cancer cells [16].”
BackgroundNarayan, M., Seeley, K. W., & Jinwal, U. K. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.09.024 · Cited by 22
Tang, J., Cheng, Y., Chuang, Y.-T., Yang, K., Chang, F., Liu, W., & Chang, H. (2022) · Cells · doi:10.3390/cells11060961 · Cited by 21
Chaudhary, A., Kalra, R. S., Huang, C., Prakash, J., Kaul, S. C., & Wadhwa, R. (2017) · Journal of Natural Products · doi:10.1021/acs.jnatprod.7b00573 · Cited by 20
Zong, S., Li, J., Yang, L., Huang, Q., Hou, G., Ye, Z., & Ye, M. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28202 · Cited by 20
“Apoptotic morphological changes in the nuclear chromatin of cells were detected by Hoechst 33258 staining (Li et al., 2015).”
MethodXue, W., Men, S., & Liu, R. (2020) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13320 · Cited by 20
RetractedPiao, L., Zhao, C., Lu, W.-J., Xiaoli, C., Shi, W., & Lu, L. (2016) · Molecular Immunology · doi:10.1016/j.molimm.2016.10.010 · Cited by 17
The Therapeutic Effects of Withaferin A against Cancer: Overview and Updates
Abeesh, P., & Guruvayoorappan, C. (2023) · Current Molecular Medicine · doi:10.2174/1566524023666230418094708 · Cited by 16
DACH 1 inhibits glioma invasion and tumor growth via the Wnt/catenin pathway
Wang, J., Zou, Y., Wu, X., Chen, M., Zhang, S., Lu, X., & Wang, Q. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s168314 · Cited by 16
“Thus, GSK-3 β was examined via Western blotting following transfection.”
InfluentialIron-crosslinked Rososome with robust stability and high drug loading for synergistic cancer therapy
Xue, X., Ricci, M., Qu, H., Lindstrom, A. R., Zhang, D., Wu, H., Lin, T., & Li, Y. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.10.013 · Cited by 16
Yan, D., Xu, X., Ren, C., Chen, C., Luo, J., Han, C., & Kong, L. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.02.033 · Cited by 16
Hua, S., Yang, L., Gao, T., Jiang, P., Jiang, F., & Liu, Y. (2019) · ACS Applied Bio Materials · doi:10.1021/acsabm.9b00784 · Cited by 16
Traditional Ayurvedic medicines: Pathway to develop anti-cancer drugs
Bhandariab, M., & Sc, A. R. (2015) · Journal of Molecular Pharmaceutics & Organic Process Research · doi:10.4172/2329-9053.1000130 · Cited by 15
“Recent studies conducted by Li Xu and coauthors [60] suggest the synergistic antitumor activity of withaferin A combined with oxaliplatin.”
BackgroundHou, W., Miao, X.-H., Ma, L., Bai, X., Liu, Q., & Song, L. (2017) · African Journal of Traditional Complementary and Alternative Medicines · doi:10.21010/ajtcam.v14i2.33 · Cited by 15
“Few studies also indicated that WFA can act as pro-oxidant and thus trigger oxidative stress to induce apoptosis (Vyas and Singh, 2014; Li et al., 2015).”
BackgroundDrug carrier for sustained release of withaferin A for pancreatic cancer treatment
Shao, Q., Feng, Y., Wang, W., Wang, M., Li, B., Tahchi, M. R. E., & Yin, Y. (2019) · Journal of Materials Science · doi:10.1007/s10853-019-04139-7 · Cited by 14
“WA could active AKT; then AKT would increase the amount of the reactive oxygen species (ROS), and ROS inhibited signal pathway of the AKT to decrease the expression of AKT [9, 52].”
BackgroundInfluentialKumar, P., Banik, S. P., Goel, A., Chakraborty, S., Bagchi, M., & Bagchi, D. (2023) · Journal of the American Nutrition Association · doi:10.1080/27697061.2023.2228863 · Cited by 14
Venom of Viperidae: A Perspective of its Antibacterial and Antitumor Potential
Teodoro, A., Gonçalves, F. J. M., Oliveira, H., & Marques, S. M. (2021) · Current Drug Targets · doi:10.2174/1389450122666210811164517 · Cited by 14
Role of Phytoconstituents in Cancer Treatment: A Review
Kumar, M., Gupta, S., Kalia, K., & Kumar, D. (2024) · Recent Advances in Food Nutrition & Agriculture · doi:10.2174/012772574x274566231220051254 · Cited by 13
Prasad, K., Saggam, A., Guruprasad, K. P., Tillu, G. S., Patwardhan, B., & Satyamoorthy, K. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118261 · Cited by 14
Wu, T., Yu, Y., Tu, X., Ye, L., Wang, J., Xie, C., Kuang, K., Yu, Y., Zhuge, W., Wang, Z., et al. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118754 · Cited by 13
Marlow, M. M., Shah, S. S., Véliz, E. A., Ivan, M. E., & Graham, R. M. (2016) · Journal of Natural Medicines · doi:10.1007/s11418-016-1020-2 · Cited by 13
Devabattula, G., Panda, B., Yadav, R., & Godugu, C. (2024) · Planta Medica · doi:10.1055/a-2289-9600 · Cited by 12
Gupta, S., Kumar, A., & Tejavath, K. K. (2021) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-021-00246-y · Cited by 11
“When reasons for apoptosis induction were checked, it was concluded that the treatment caused mitochondrial membrane damage that leads to high levels of ROS generation that resulted in triggering of apoptosis and ultimately death of the cancer cells [48].”
BackgroundInfluentialSzydlak, R. (2024) · Biomolecules · doi:10.3390/biom14091178 · Cited by 10
“To overcome these limitations, combination therapies involving gemcitabine and other chemotherapeutic agents or molecularly targeted drugs have been explored [9,11–14].”
BackgroundWang, Z., Qu, K., Zhou, L., Ren, L., Ren, B., Meng, F., Yu, W., Wang, H., & Fan, H. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.08.030 · Cited by 10
Zhang, X., Chen, X., Sun, P., Su, X.-M., Zeng, H., Zeng, Y., Wang, M., & Luo, X. (2020) · Technology in Cancer Research & Treatment · doi:10.1177/1533033820928073 · Cited by 9
“Malondialdehyde concentration in the homogenates was determined spectrophotometrically by measuring the presence of thiobarbituric acid reactive substances (utilizing the principle of the thiobarbituric acid colorimetric method).(29,30) Superoxide dismutase was detected by a corresponding assay kit based on the princi…”
MethodMesas, C., Fuel, M., Martínez, R., Prados, J. C., Melguizo, C., & Porres, J. M. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1900058 · Cited by 9
“…few last years, active biological drugs for advanced CRC have been developed, including the monoclonal antibodies cetuximab, panitumumab, bevacizumab, and a recombinant fusion protein (aflibercept) which has very precise indications (Loree and Kopetz 2017; Nappi et al. 2018; Bregni et al. 2020).”
BackgroundChemotherapeutic Effect of Withaferin A in Human Oral Cancer Cells
Yang, I., Kim, L., Shin, J., & Cho, S. (2015) · Journal of Cancer Therapy · doi:10.4236/jct.2015.68080 · Cited by 8
“Recently, WA-induced apoptosis has been studied in various cancer cell lines, such as breast [18], prostate [19], pancreatic [20], ovarian [21], lung [22], head and neck cancer cell lines [23].”
BackgroundNiu, Y.-B., Velu, P., Khalid, A., Zyoud, S. H., Kazi, M., & Li, Y. (2024) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/0113862073297703240613073134 · Cited by 7
Volpe-Fix, A. R., Sales, F. S., Caperuto, L. C., Lago, J. H. G., & Machado, J. (2024) · Chemistry & Biodiversity · doi:10.1002/cbdv.202401530 · Cited by 7
Kitahara, T., Haraguchi, N., Takahashi, H., Nishimura, J., Hata, T., Takemasa, I., Mizushima, T., Yamamoto, H., Doki, Y., & Mori, M. (2016) · Annals of Surgical Oncology · doi:10.1245/s10434-016-5671-8 · Cited by 7
“2a), we found increased ROS levels in HT29 cells, which indicated that L-OHP induced ROS, as previously reported.(7,8) After 72 h’ L-OHP exposure (4 lM), the ROS cell fraction was reduced from 93.”
Wang, R., Liao, Z., Liu, C., Yu, S., Xiang, K., Wu, T., Feng, J., Ding, S., Yu, T., Cheng, G., et al. (2024) · The Journal of Biochemistry · doi:10.1093/jb/mvae052 · Cited by 6
Song, Y., Lyu, S., Wang, R., Hou, X., Tong, X., Fang, Y., Zhang, Z., Liu, A., Yang, M. G., Li, Y., et al. (2025) · NanoImpact · doi:10.1016/j.impact.2025.100590 · Cited by 5
Liu, X., Guo, M., Yang, Q., Shi, M., Liu, G., & Peng, F. (2020) · Pharmacognosy Magazine · doi:10.4103/pm.pm_499_19 · Cited by 3
Experimental evidence to the untapped potential of Ayurvedic herb, Ashwagandha: Bench-to-Bedside
Wadhwa, R., & Kaul, S. C. (2023) · International Journal of Ayurveda Research · doi:10.4103/ijar.ijar_6_23 · Cited by 3
Withania somnifera Has Potential to Treat Cancer
Halder, B., & Thakur, S. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-59192-6_10 · Cited by 3
Sehrawat, A., Samanta, S. K., Kim, S., Hahm, E., & Singh, S. V. (2017) · Springer eBooks · doi:10.1007/978-3-319-59192-6_8 · Cited by 3
Shikder, M., Hasib, T. A., & Kabir, M. L. (2020) · ChemRxiv · doi:10.26434/chemrxiv.13038236 · Cited by 3
“Withaferin-A functions as a cancer chemotherapeutic agent, anti-proliferative agent, anti-oxidant agent, cardioprotective agent and neuroprotective agent [29][30][31][32][33][34].”
BackgroundWijeratne, E. M. K., Xu, Y.-M., Padumadasa, C., Astashkin, A. V., & Gunatilaka, A. A. L. (2024) · Journal of Natural Products · doi:10.1021/acs.jnatprod.3c01003 · Cited by 2
Exploring the therapeutic potential of withaferin A by modulating key oncosignaling pathways
Chauhan, P., Mallick, M. N., Rab, S. O., Saeed, M., Alkhulaifi, F. M., Lakhanpal, S., Singh, A. V., Pandey, P., Verma, M., & Khan, F. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05006-4 · Cited by 2
Yuan, R., Liu, G., Guo, M., & Liu, X. (2023) · Indian Journal of Pharmaceutical Education and Research · doi:10.5530/ijper.57.4.135 · Cited by 2
“24,25 In recent years, the research on the mechanism of the killing effect of drugs on tumor cells mainly focuses on the effects of drugs on the proliferation, differentiation and apoptosis of tumor cells, as well as the control of oncogenes and tumor suppressor genes, and immune regulation.”
BackgroundAshwagandha Bioactives for Cancer Treatment: Experimental Evidence and Their Mechanism(s) of Action
Wadhwa, R., Garg, S., Kaul, A., & Kaul, S. C. (2017) · Springer eBooks · doi:10.1007/978-3-319-59192-6_7 · Cited by 2
Shikder, M., Hasib, T. A., & Kabir, M. L. (2020) · ChemRxiv · doi:10.26434/chemrxiv.13038236.v1 · Cited by 2
Molecular insights into withaferin A: A holistic approach to cancer therapy
Islam, M. R., Rauf, A., Rakesh, M. M., Akash, S., Fakir, M. N. H., Islam, M. S., Naba, A. F., Al-Imran, M. I. K., Alomar, T. S., Ogaly, H. A., et al. (2024) · Inorganic Chemistry Communications · doi:10.1016/j.inoche.2024.113316 · Cited by 1
Current progress of CDC20 in cancer development and targeting CDC20 for cancer therapy
Chen, Y., Gao, S., Yang, P., Liu, S., Zhang, W., Wang, J., & Jing, H. (2026) · Carcinogenesis · doi:10.1093/carcin/bgag021 · Cited by 1
WithaniaSomnifera: A New Approach To Cancer
Shah, D. R., Palaskar, S. J., Pawar, R., & Punse, R. R. (2018) · Annals of Applied Bio-Sciences · doi:10.21276/aabs.1838 · Cited by 1
“WS promoted growth suppression and apoptosis through ROSmediated mitochondrial dysfunction and by inhibition of the PI3K/AKT pathway whereas in invivo, showed potential anti-tumor effects compared to single factor administered, without much side effects and toxicity.[38] Further studies of WA on PC cell lines like Pan…”
BackgroundWhy Ashwagandha for Healthy Ageing? Evidence from Cultured Human Cells
Wadhwa, R., Garg, S., Khurana, M., & Kaul, S. C. (2021) · Healthy ageing and longevity · doi:10.1007/978-3-030-83017-5_28 · Cited by 1
Metadata
- Authors
- Li, X., Zhu, F., Jiang, J., Sun, C., Wang, X., Shen, M., Tian, R., Shi, C., Xu, M., Peng, F., Guo, X., Wang, M., & Qin, R.
- Affiliations
- Tongji Hospital (CN)
- Guiyang Medical University (CN)
- Corresponding author
- Wang, Min
- Qin, Renyi
- ORCID
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2015-02
- Volume
- 357
- Issue
- 1
- Pages
- 219-230
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2032234787
- Cited by
- 116
- References
- 51
- Citations by year
- 2026: 5 · 2025: 2 · 2024: 14 · 2023: 10 · 2022: 9 · 2021: 11 · 2020: 19 · 2019: 11 · 2018: 6 · 2017: 14 · 2016: 8 · 2015: 7
- FWCI
- 20.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Letters (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81272659, 81101621, 81160311, 81372353, 81172064, 81301860)
- National “Eleventh Five-Year” Scientific and Technological Support Projects (2006BAI02A13-402)
- Projects of Science Foundation of Hubei Province (2012FFB02401)
- International S&T Cooperation Projects of China (2014DFA31420)
- Research Fund of Young Scholars for the Doctoral Program of Higher Education of China (20110142120014)
- Topics
- Health Sciences › Medicine › Complementary and alternative medicine › Phytochemicals and Medicinal Plants
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacological Effects of Medicinal Plants
- Keywords
- withaferin A, oxaliplatin, pancreatic cancer, combination chemotherapy, synergistic antitumor effect, reactive oxygen species, PI3K/Akt signaling, apoptosis, mitochondrial dysfunction, N-acetylcysteine, drug resistance, Withania somnifera
- MeSH terms
- Oxaliplatin, Animals, Antineoplastic Combined Chemotherapy Protocols, Drug Synergism, Humans, Male, Mice, Inbred BALB C, Mice, Nude, Organoplatinum Compounds, Pancreatic Neoplasms, Prognosis, Random Allocation, Signal Transduction, Apoptosis, Reactive Oxygen Species, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt, Mice, Withanolides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review